AGP Executive Report
Last update: 8 hours agoDementia Care Breakthrough: A first-of-its-kind LiBBY trial reported that a THC+CBD medical formulation significantly reduced agitation in late-stage dementia, with close to 90% showing improvement after 12 weeks—results presented at the Alzheimer’s Association conference in London. Medical Policy & Guns: Hawaii police updated firearm permitting rules after a U.S. Supreme Court decision, saying holders of valid medical cannabis licenses won’t be automatically disqualified and will be assessed case-by-case. Clinical Pipeline Watch: Neurotech shares jumped after the FDA granted Investigational New Drug status for its medicinal cannabis program targeting childhood autism, clearing the way for a phase III trial pathway. Public Safety & Enforcement: Kenya police arrested four suspects and seized more than 230 rolls of bhang in anti-drug operations in Machakos and Bungoma. Animal Health Alert: Scotland’s Ben Nevis rescue team saved a Labrador after vets believed it ate discarded cannabis on the trail, prompting warnings for pet owners. Regulatory/Legal Signals: An Ohio hemp law was halted in a dormant commerce fight, while a separate court dispute in Delaware turned on director-related issues. Industry Finance: Red White & Bloom closed a Florida divestiture expected to eliminate over $123M in liabilities and reduce future funding obligations.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.